Drugs Health Pharma

Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA

Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.

Read More
Health Medical Pharma

FDA warns 8 firms for marketing harmful eye products 

HQ Team September 12, 2023: The USFDA, in a bid to protect consumers, has issued warning letters to eight companies for marketing illegal.

Read More
Drugs Health Pharma

Viatris acquires two companies for $750 million to sharpen ophthalmology vision

Viatris acquires two companies for $750 million to fuel ophthalmology vision

Read More
X